Development of a docetaxel micellar formulation using poly(Ethylene glycol)–polylactide–poly(ethylene glycol) (PEG–PLA–PEG) with successful reconstitution for tumor targeted drug delivery

Taehoon Sim, Jae Eun Kim, Ngoc Ha Hoang, Jin Kook Kang, Chaemin Lim, Dong Shik Kim, Eun Seong Lee, Yu Seok Youn, Han Gon Choi, Hyo Kyung Han, Kwon Yeon Weon, Kyung Taek Oh

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Docetaxel (DTX)-loaded polymeric micelles (DTBM) were formulated using the triblock copolymer, poly(ethylene glycol)–polylactide–poly(ethylene glycol) (PEG–PLA–PEG), to comprehensively study their pharmaceutical application as anticancer nanomedicine. DTBM showed a stable formulation of anticancer nanomedicine that could be reconstituted after lyophilization (DTBM-R) in the presence of PEG 2000 and D-mannitol (Man) as surfactant and protectant, respectively. DTBM-R showed a particle size less than 150nm and greater than 90% of DTX recovery after reconstitution. The robustly formed micelles might minimize systemic toxicity due to their sustained drug release and also maximize antitumor efficacy through increased accumulation and release of DTX from the micelles. From the pharmaceutical development point of view, DTBM-R showing successful reconstitution could be considered as a potent nanomedicine for tumor treatment.

Original languageEnglish
Pages (from-to)1371-1380
Number of pages10
JournalDrug Delivery
Volume25
Issue number1
DOIs
StatePublished - 2018

Keywords

  • Cancer
  • Lyophilization
  • Nanomedicine
  • Polymeric micelle
  • Reconstitution

Fingerprint

Dive into the research topics of 'Development of a docetaxel micellar formulation using poly(Ethylene glycol)–polylactide–poly(ethylene glycol) (PEG–PLA–PEG) with successful reconstitution for tumor targeted drug delivery'. Together they form a unique fingerprint.

Cite this